ECSP003541A - COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES - Google Patents

COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES

Info

Publication number
ECSP003541A
ECSP003541A ECSP003541A ECSP003541A EC SP003541 A ECSP003541 A EC SP003541A EC SP003541 A ECSP003541 A EC SP003541A EC SP003541 A ECSP003541 A EC SP003541A
Authority
EC
Ecuador
Prior art keywords
combination
inhibitors
coa reductase
medicines
hmg coa
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Hilmar Bischoff
Rudi Gruetzmann
Ulrich Muller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003541 priority Critical patent/ECSP003541A/en
Publication of ECSP003541A publication Critical patent/ECSP003541A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere al uso de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención.The invention relates to the use of a combination of at least one selected MTP inhibitor (component A) and an HMg-CoA reductase inhibitor (component B) for the fight against diseases of the cardiovascular system, to medicines containing this combination and to their obtaining.

ECSP003541 2000-06-23 2000-06-23 COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES ECSP003541A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003541 ECSP003541A (en) 2000-06-23 2000-06-23 COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003541 ECSP003541A (en) 2000-06-23 2000-06-23 COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES

Publications (1)

Publication Number Publication Date
ECSP003541A true ECSP003541A (en) 2000-10-24

Family

ID=42041159

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003541 ECSP003541A (en) 2000-06-23 2000-06-23 COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES

Country Status (1)

Country Link
EC (1) ECSP003541A (en)

Similar Documents

Publication Publication Date Title
PA8577901A1 (en) PHARMACEUTICAL FORMULATION
EE04990B1 (en) Pharmaceutical compositions containing an HMG reductase inhibitor, their use and method of preparation
BRPI0413363A (en) dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
BR0317715A (en) Compositions and processes of use of collajolie
DOP2000000022A (en) COMBINATION OF MTP INHIBITORS AND INHIBITORS OF HMG-COA REDUCTASA AND ITS USE IN MEDICINES.
PA8523901A1 (en) PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTEIN
PA8564901A1 (en) PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE CHOLESTERILE ESTERES TRANSFER PROTEIN
UY29391A1 (en) A SOLID FORMULATION OF PHARMACEUTICAL DOSAGE
PA8513601A1 (en) PHARMACEUTICAL COMPOSITIONS OF GLUCOGENOPHOSPHORILASE INHIBITORS
DE60202452D1 (en) PYRIDAZINONAL DOSE REDUCTASE INHIBITORS
HN2003000227A (en) KINASE INHIBITORS
HN2001000146A (en) PIRAZOL DERIVATIVES
CO5550464A2 (en) COMBINATION OF AN ALDOSTERONE RECEIVER AGONIST WITH AN HMG INHIBITOR
BRPI0410555A (en) solid preparation
CY1108725T1 (en) Combination of NMDA antagonist and acetylcholinesterase inhibitors for the treatment of ALZHEIMER
BRPI0413468A (en) pyrrol-based hmg-coa reductase inhibitors
ES2161548T3 (en) COMBINATION OF AN INHIBITOR OF ALDOSA REDUCTASA AND AN INHIBITOR OF GLUCOGENO FOSFORILASA.
CR8824A (en) DERIVATIVES OF 2-CARBAMIDA-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
BRPI0507652A (en) pharmaceutical compositions comprising a benzoidiazepine derivative and an rsv fusion protein inhibitor
BRPI0507654A (en) pharmaceutical composition comprising a benzodiazepine derivative and an rsv fusion protein inhibitor
CY1110906T1 (en) PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL
AR052104A1 (en) DOSAGE FORMS OF INHIBITORS OF THE PROTEIN OF TRANSFER OF ESTERES DE COLESTERILO AND INHIBITORS OF THE HMG-COA REDUCTASA
WO2003057205A3 (en) Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs
CR9521A (en) NEW METHOD OF TREATMENT OF HYPERLIPEDEMIA
DK0991424T3 (en) Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor